Associacao Hospital de Caridade Ijui

Ijuí 98700-000

0 studies enrolling now · 4 studies all time

What they study most

Advanced Solid Tumor, Cancer, Ischemic Stroke; Ischemic Attack, Transient, Metastatic Breast Cancer

Studies at this site

• A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE — Running, not enrolling
• A Study of Erdafitinib in Participants With Advanced Solid Tumors and Fibroblast Growth Factor Receptor (FGFR) Gene Alterations — Completed
• E7389 Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes — Completed
• Phase 1/2 Study of Vascular Disrupting Agent NPI-2358 + Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer — Completed